American 3D-bioprinting company Advanced Development of Additive Manufacturing, also known as A.D.A.M. has announced that the FDA has given them clearance to create 3D-printed bones.
While clinical trials for 3D printed replacement organs are still a good five to 10 years away, A.D.A.M. claims that 3D printed bones however might be less than two years away because of biocermaic materials.
The reason why is that Biocermaic materials are more compatible with the human body due to being used in bone grafting to help repair bone fractures that are more complex or fail to heal properly.
Biocermaic materials are made of osteoblasts and osteocytes which are involved in the formation and mineralization of the bone and in the resorption of bone tissue respectively.
Because of this, the company was able to complete its pre-clinical trials in Oct. of 2019, just one year after initiating its 3D bone bioprinting project in the summer of 2018.
While the concept of bioprinting is pretty sci-fi it’s actually pretty modern as its first known demonstration was in 1988, but the history of bioprinting is almost 40 years old.